Attenuated oncolytic measles virus as a new therapeutic approach against pediatric acute lymphoblastic leukemia : a proof of principle
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Ulm, Universität Ulm, Dissertation, 2018
- Keyword
-
Akute lymphatische Leukämie
Kind
Onkologie
Masernvirus
- DOI
-
10.18725/OPARU-6216
- URN
-
urn:nbn:de:bsz:289-oparu-6273-1
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:45 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zirngibl, Felix
- Universität Ulm
Time of origin
- 2018
Other Objects (12)
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Key parameters of measles virus production for oncolytic virotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Exploring the Interplay of Oncolytic Measles Vaccines with the Cancer-Immunity Cycle
Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine and Vaccinia Virus
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Key parameters of measles virus production for oncolytic virotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Exploring the Interplay of Oncolytic Measles Vaccines with the Cancer-Immunity Cycle
Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine and Vaccinia Virus
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Key parameters of measles virus production for oncolytic virotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Exploring the Interplay of Oncolytic Measles Vaccines with the Cancer-Immunity Cycle